In this session from the WFH 2020 Virtual Summit, Saliou Diop, Ampaiwan Chuansumrit, Silvia Riva and Ahmad Tarawah discuss:
The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.
The WFH does not promote any particular pharmaceutical product and any mention of any commercial brand in this presentation is strictly for educational purposes.
This information sheet is designed to help understand the similarities, differences, and current state of knowledge for the existing genetic
The global bleeding disorders community reached a major milestone in 2025, as the World Health Organization updated both its Essential
The World Federation of Hemophilia (WFH) hosted an educational webinar titled “Progress toward a cure for hemophilia: gene editing explained”
Welcome to this exciting project, a collaborative effort between the Nurses Committees of the European Association for Haemophilia and Allied
The Report on Annual Global Survey (AGS) includes demographic and treatment data, providing a global snapshot of people with hemophilia,
The World Federation of Hemophilia invited representatives from its national member organizations, national governments, healthcare providers, industry partners, and other
